Also trades as: ALTHE.PA (PAR) · $vol 0M
TCLIF OTC
Theraclion S.A.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +312841.2%
1Y: +312841.2%
3Y: -76.7%
5Y: -72.6%
$0.53
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$38.9M
52W Range0.00017-0.59
Volume100
Avg Volume91
Beta0.42
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMartin Deterre
Employees36
SectorHealthcare
IndustryMedical - Devices
IPO Date2019-04-22
Websitetheraclion.com
102 Rue Etienne Dolet
Malakoff, IF 92240
FR
Malakoff, IF 92240
FR
33 1 55 48 90 70
About Theraclion S.A.
Theraclion SA specializes in developing advanced echotherapy devices that harness high-intensity focused ultrasound technology. Its product portfolio includes SONOVEIN, a robotic, non-surgical echotherapy system specifically designed for treating varicose veins. Another key offering is ECHOPULSE, also a robotic and non-invasive echotherapy solution, utilized for addressing thyroid nodules and breast fibroadenomas. The company further provides EPack, a disposable accessory that attaches to the treatment device to ensure patient skin protection and improve imaging precision. Founded in 2004, Theraclion SA is headquartered in Malakoff, France.
Latest News
No recent news
Recent Insider Trades
No insider trades found